Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- MedStar NRH Study Finds that Innovative Devices Did Not Provide Better Outcomes for Knee Replacement Patients Undergoing Outpatient Rehabilitation
Researchers from MedStar National Rehabilitation Hospital and MedStar Health Physical Therapy were a... - MedStar Health Research Evaluates Diabetes Survival Skills Education for Behavioral Health Inpatients
Researchers from across MedStar Health sought to adapt Diabetes to Go (D2Go), a diabetes survival sk... - October Peer-Reviewed Publications from MedStar Health
Congratulations to all MedStar researchers who had articles published in October 2020. The selected ...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]